Advertisement

Indian

Nearly Rs 49,000 cr lying unclaimed with banks, insurers: Karad

As per the Insurance Regulator Development Authority of India (IRDAI), the total amount of unclaimed amounts of policy holders in public and private sector insurance companies was at Rs 24,586 crore (end-December, 2020).
On the other hand, all insurers having unclaimed amounts of policyholders for a period of more than 10 years transfer such funds to the Senior Citizens” Welfare Fund (SCWF) every year. The SCWF is utilised for schemes for promoting the welfare of senior citizens.

Church in Kerala announces welfare scheme for large Christian families

“During the formation of Kerala, Christians were the second largest community in the state. But now, the community is only 18.38 per cent of the state’s total population. In recent years, the birth rate in the Christian community has decreased to 14 per cent,” read the letter, issued by the Archbishop Mar Joseph Perumthottam in 2019.

International

Aon & partners deliver pay-outs with first Blockchain-Based Agricultural Insurance Policies for smallholder farmers in Sri Lanka

After the coordinated launch earlier this year with 200 farmers enrolled who are at risk of losing their crops due to extreme weather, the system made pay-outs to farmers in this initial operations phase. The companies will now move forward by seeking solutions to some of the challenges identified in the next phase of the project as cropping season starts in November. The main goals of this follow-on phase are to refine the system’s efficiency and scale the number of farmers who will benefit from the microinsurance

Wall Street increasingly weighs risk from climate change

The increase in wildfires has prompted underwriters, such as Hiscox Ltd to incorporate new risks models and stop insuring some clients in high-risk areas such as California.Overall, 10% of insurers refused to renew policies in wildfire-prone areas in California in 2018, according to the California Department of Insurance.

New FDA warning letters show Indian drug makers’ quality concerns persist

The latest regulatory crackdown shows US regulator’s stance is hardening toward lapses in quality control even as it seeks cheaper drugs to contain health care costs. Indian pharmaceutical factories collectively produce about 40 per cent of the American generic drug supply and have been faulted in the past by the FDA for everything from lax documentation to open toilet drains and malfunctioning equipment.

Briefs

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Events

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Advertisement

Articles

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Features

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Data

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Interviews

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Facts

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.